Restructuring the Balance Sheet of an ESOP Owned Company

This year is expected to be full of opportunity for many privately held companies, including those owned by Employee Stock Ownership Plans (ESOPs). An essential component for companies to take advantage of these opportunities is a proper capital structure.

Recapitalizing or restructuring the balance sheet occurs in the public and private marketplace on a regular basis. Recent highly publicized examples include the government equity infusions in U.S.-based financial institutions and auto manufacturers. ESOP-owned companies should similarly avail themselves of opportunities to adjust their capital structure.

While this article addresses some of the unique capital structures of ESOPs, many of these capital restructuring strategies apply to all companies.

Reasons to recapitalize / restructure the balance sheet include:

  • Reduce high interest cost and stop accruing interest
  • Free cash flow for growth and expansion
  • Comply with senior debt covenants
  • Match return of seller instruments with risks
  • Generate new capital to reduce debt or meet growth opportunities

The sale of stock to an ESOP is usually a leveraged transaction facilitated by outside or seller financing which is then used by the ESOP to buy stock in the company. In the case of seller financing, the former shareholders can choose to defer interest and principal payments to improve the cash flow of the business and, as a result, delay their liquidity event.

An alternative to deferring, or forgiving payments, involves writing down or exchanging a portion of the seller debt in return for equity or synthetic equity. This provides flexibility to the company by freeing up cash flow and offers the debt holder (seller) the appropriate return for reducing the amount owed. From a fiduciary perspective, the dilution of the ESOP by the issuance of equity (including synthetic) has to be weighed against the viability of the company (and value of the ESOP) if the debt was not exchanged.

If an ESOP-owned company is having trouble servicing debt held by an outside lender, an equity infusion might be the best course of action. In an S-Corporation, this can be difficult as many institutional investors are not qualified investors for S-Corporations but there are other strategies that work. For C-Corporations, the universe of potential investors is much larger. Investors familiar with ESOPs see this as a great time to invest in ESOP-owned companies, given the compelling economics and intangible factors that ESOPs provide.

Significant changes to capital structure may involve shareholder or board approval. In an ESOP-owned company fiduciary concerns need to be addressed for any action that may impact the employee-owners. This should be easy to achieve with a well-designed plan since any recapitalization or restructuring is executed to provide a better future for all parties involved.

If restructuring the balance sheet is important for your business, this is an opportune time to restructure seller notes, raise equity to reduce bank debt or execute growth strategies.

If you have comments or questions about this article, or would like more information on this subject matter, please contact us.

Largest Transactions Closed

  • Target
  • Buyer
  • Value($mm)
David Jasmund

 

David Jasmund

Investment Banking | ESOP

Orlando Office

407-621-2111 (direct)

djasmund@pcecompanies.com

Connect
407-621-2111 (direct)

407-621-2199 (fax)

Eric Zaleski

 

Eric Zaleski

Investment Banking | ESOP

Chicago Office

847-239-2466 (direct)

ezaleski@pcecompanies.com

Connect
847-239-2466 (direct)

407-621-2199 (fax)

Melissa Ritter

 

Melissa Ritter

Investment Banking

Orlando Office

407-621-2128 (direct)

mritter@pcecompanies.com

Connect
407-621-2128 (direct)

407-621-2199 (fax)

Michael Rosendahl

 

Michael Rosendahl

Investment Banking

New York Office

201-444-6280 Ext 1 (direct)

mrosendahl@pcecompanies.com

Connect
201-444-6280 Ext 1 (direct)

407-621-2199 (fax)

Will Stewart

 

Will Stewart

Investment Banking | ESOP

Orlando Office

407-621-2124 (direct)

wstewart@pcecompanies.com

Connect
407-621-2124 (direct)

407-621-2199 (fax)

whitcomb-woody

 

Woody Whitcomb

Investment Banking

Orlando Office

407-621-2113 (direct)

wwhitcomb@pcecompanies.com

Connect
407-621-2113 (direct)

407-621-2199 (fax)

poole_michael

 

Michael Poole

Investment Banking

Orlando Office

407-621-2112 (direct)

mpoole@pcecompanies.com

Connect
407-621-2112 (direct)

407-621-2199 (fax)

vogt-paul

 

Paul Vogt

Valuation

Atlanta Office

678-641-4760 (direct)

pvogt@pcecompanies.com

Connect
678-641-4760 (direct)

407-621-2199 (fax)

Mackenzie Moran

 

Mackenzie Moran

Investment Banking

New York Office

201-444-6280 Ext 3 (direct)

mmoran@pcecompanies.com

Connect
201-444-6280 Ext 3 (direct)

407-621-2199 (fax)

Isabel Carta

 

Isabel Carta

Investment Banking

Orlando Office

407-621-2149 (direct)

icarta@pcecompanies.com

Connect
407-621-2149 (direct)

407-621-2199 (fax)

Philipp Seubert

 

Philipp Seubert

Investment Banking

New York Office

201-444-6280 Ext 4 (direct)

pseubert@pcecompanies.com

Connect
201-444-6280 Ext 4 (direct)

407-621-2199 (fax)

Please Share This

    Services

    Industries

    Subscribe to PCE Communications

    Choose Your Subscription